Multicenter phase II trial to investigate safety and efficacy of an adjuvant therapy with gemcitabine and cetuximab in patients with R0 or R1 resected pancreatic cancer.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 4039-4039
Author(s):  
H. Fensterer ◽  
C. Schade-Brittinger ◽  
H. Mueller ◽  
B. Schupfner ◽  
J. Fass ◽  
...  
2013 ◽  
Vol 24 (10) ◽  
pp. 2576-2581 ◽  
Author(s):  
H. Fensterer ◽  
C. Schade-Brittinger ◽  
H.-H. Müller ◽  
S. Tebbe ◽  
J. Fass ◽  
...  

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 4505-4505 ◽  
Author(s):  
V. J. Picozzi ◽  
R. A. Abrams ◽  
L. W. Traverso ◽  
E. M. O’Reilly ◽  
E. Greeno ◽  
...  

2003 ◽  
Vol 13 (7) ◽  
pp. 1620-1627 ◽  
Author(s):  
Tim Leiner ◽  
Kai Yiu J. A. M. Ho ◽  
Vincent B. Ho ◽  
Georg Bongartz ◽  
Willem P. T. M. Mali ◽  
...  

2018 ◽  
Vol 10 (12) ◽  
pp. 505-515 ◽  
Author(s):  
Moon Jae Chung ◽  
Huapyong Kang ◽  
Ho Gak Kim ◽  
Jong Jin Hyun ◽  
Jun Kyu Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document